
	<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
	<html><head>
	<meta http-equiv="content-type" content="text/html; charset=windows-1252">
	<title>Xapian_query_results</title>
	</head>
	<body>

	<table border="1" width="100%">
	  <tbody><tr>
		<th>Rank</th>
		<th>PubMed-ID</th>
		<th>Title (query term highlighted)</th>
	  </tr>
	<tr><td>0</td><td>22472062</td><td>Cardiovascular disease (<b>CVD</b>) limbo: how soon and low should we go to prevent <b>CVD</b> in diabetes?</td></tr><tr><td>1</td><td>23156837</td><td><b>CVD</b> health factors and <b>CVD</b> risk factors: state of the science, emerging priorities part 2: obesity prevention.</td></tr><tr><td>2</td><td>11708592</td><td>Major cardiovascular disease (<b>CVD</b>) during 1997-1999 and major <b>CVD</b> hospital discharge rates in 1997 among women with diabetes--United States.</td></tr><tr><td>3</td><td>16868574</td><td>Will a web-based cardiovascular disease (<b>CVD</b>) risk assessment programme increase the assessment of <b>CVD</b> risk factors for Maori?</td></tr><tr><td>4</td><td>26222883</td><td>Cardiovascular disease (<b>CVD</b>) in Canadians with haemophilia: Age-Related <b>CVD</b> in Haemophilia Epidemiological Research (ARCHER study).</td></tr><tr><td>5</td><td>28245267</td><td>Knowledge of risk factors for diabetes or cardiovascular disease (<b>CVD</b>) is poor among individuals with risk factors for <b>CVD</b>.</td></tr><tr><td>6</td><td>12477139</td><td>Differential impact of cardiovascular disease (<b>CVD</b>) risk factor clustering on <b>CVD</b> and renal disease among African-American and white patients with type 2 diabetes mellitus.</td></tr><tr><td>7</td><td>17288695</td><td>Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (<b>CVD</b>) and men with <b>CVD</b> alone in a US commercial population.</td></tr><tr><td>8</td><td>28964324</td><td>Coffee consumption is not associated with prevalent subclinical cardiovascular disease (<b>CVD</b>) or the risk of <b>CVD</b> events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis.</td></tr><tr><td>9</td><td>18637168</td><td>The impact of individualised cardiovascular disease (<b>CVD</b>) risk estimates and lifestyle advice on physical activity in individuals at high risk of <b>CVD</b>: a pilot 2 x 2 factorial understanding risk trial.</td></tr><tr><td>10</td><td>17853933</td><td>The impact of New Zealand <b>CVD</b> risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT <b>CVD</b>-5).</td></tr><tr><td>11</td><td>29365466</td><td>Apabetalone (RVX-208) may lower <b>CVD</b> events in diabetes mellitus by affecting complement pathway and microbiome activity.</td></tr><tr><td>12</td><td>27811933</td><td>Diabetes: Lipidomics refines <b>CVD</b> risk prediction.</td></tr><tr><td>13</td><td>28774376</td><td>Leaving the Glucocentric View: Can SGLT2 Inhibitors Halt <b>CVD</b> in Patients With Type 2 Diabetes?</td></tr><tr><td>14</td><td>27750299</td><td>In patients with type 2 diabetes and <b>CVD</b>, empagliflozin reduced incident or worsening nephropathy at 3.1 y.</td></tr><tr><td>15</td><td>26857996</td><td>Access to medicines for <b>CVD</b>-what's the trade-off?</td></tr><tr><td>16</td><td>28126461</td><td>New country-specific <b>CVD</b> risk charts: recalibrate and refine.</td></tr><tr><td>17</td><td>26926617</td><td>Preventing <b>CVD</b> in Adults with Type 2 Diabetes Mellitus: An Update from the AHA and ADA.</td></tr><tr><td>18</td><td>28566531</td><td>SDHB mutation carriers with malignant pheochromocytoma respond better to <b>CVD</b>.</td></tr><tr><td>19</td><td>26701217</td><td>Diabetes: Lixisenatide does not increase rates of <b>CVD</b> events.</td></tr><tr><td>20</td><td>22641078</td><td>Chronic kidney disease: Albuminuria or CKD stage as best marker of <b>CVD</b> in diabetes?</td></tr><tr><td>21</td><td>25825947</td><td>Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality Autonomic Imbalance Predicts <b>CVD</b>, DM, Mortality.</td></tr><tr><td>22</td><td>25348438</td><td>Gestational diabetes is a significant <b>CVD</b> risk factor.</td></tr><tr><td>23</td><td>27201479</td><td>The Intermediate Burden Of Diabetes Mellitus In Patients With Cardiovascular Disease (<b>Cvd</b>): A Quality Adjusted Life Year (Qaly) -Analysis Based On Primary Longitudinal Data.</td></tr><tr><td>24</td><td>24935121</td><td>Therapy: Statin potency is associated with risk of new-onset diabetes in patients with <b>CVD</b>.</td></tr><tr><td>25</td><td>24209598</td><td>Response to the Letter by Kawada et al. regarding the manuscript entitled "The metabolic syndrome and <b>CVD</b> outcomes for a central Australian cohort".</td></tr><tr><td>26</td><td>23612952</td><td>Consequences of underlying infection complicate <b>CVD</b> management in Africa.</td></tr><tr><td>27</td><td>23540681</td><td>The metabolic syndrome and <b>CVD</b> outcomes for a central Australian cohort.</td></tr><tr><td>28</td><td>18958921</td><td>Intense diabetes treatment & <b>CVD</b>.</td></tr><tr><td>29</td><td>20725103</td><td>Prevention: Reducing the risk of <b>CVD</b> in patients with periodontitis.</td></tr><tr><td>30</td><td>17425910</td><td>The role of PPAR-alpha agonists in the prevention of <b>CVD</b> in diabetes.</td></tr><tr><td>31</td><td>16913027</td><td>Is cardiovascular disease a risk factor for dementia? Common <b>CVD</b> risk factors correlate with cognitive impairment.</td></tr><tr><td>32</td><td>17181119</td><td>North Carolina initiative targets <b>CVD</b> and diabetes with telehealth intervention.</td></tr><tr><td>33</td><td>17213107</td><td>Long term fenofibrate did not reduce major coronary events but may reduce total <b>CVD</b> events in type 2 diabetes.</td></tr><tr><td>34</td><td>19931497</td><td>Diabetes therapy and cancer; diabetes and <b>CVD</b> in people with severe mental illness--thoughts from Vienna.</td></tr><tr><td>35</td><td>19474631</td><td><b>CVD</b> risk. License to screen: a new mobile intervention program.</td></tr><tr><td>36</td><td>19192416</td><td>Inhibition of the RAS and prevention of diabetes and <b>CVD</b>: mechanistic insights and lessons learned from clinical trials.</td></tr><tr><td>37</td><td>16646609</td><td>Long-term fenofibrate therapy did not reduce major coronary events but may reduce total <b>CVD</b> events in type 2 diabetes mellitus.</td></tr><tr><td>38</td><td>16522276</td><td>Endothelial function and the prediction of <b>CVD</b> in diabetes.</td></tr><tr><td>39</td><td>16522273</td><td>The role of postprandial hyperglycemia and hyperlipidemia in <b>CVD</b> risk.</td></tr><tr><td>40</td><td>15929865</td><td>Statins and <b>CVD</b> prevention in the diabetic population: implications of the CARDS trial.</td></tr><tr><td>41</td><td>15915283</td><td>Kidney disease as <b>CVD</b> risk factor: implications for therapy.</td></tr><tr><td>42</td><td>14964157</td><td>Use it or lose it: exercise, diabetes and <b>CVD</b>.</td></tr><tr><td>43</td><td>12639823</td><td>Obesity and oxidative stress: a direct link to <b>CVD</b>?</td></tr><tr><td>44</td><td>12017817</td><td>Cardiovascular disease (<b>CVD</b>) risk factors in Samoa and American Samoa, 1990-95.</td></tr><tr><td>45</td><td>11897295</td><td>South Asia's governments exhorted to focus on <b>CVD</b>.</td></tr><tr><td>46</td><td>21222055</td><td>What's wrong with too low? Is hypoglycemia a marker or a cause of <b>CVD</b> and mortality risk?</td></tr><tr><td>47</td><td>20643979</td><td>Etiology. Higher "normal" glycated hemoglobin levels were associated with increased risk for diabetes, <b>CVD</b>, stroke, and mortality in adults.</td></tr><tr><td>48</td><td>20104677</td><td>Which risk engines are best to assess <b>CVD</b> risk in diabetes?</td></tr><tr><td>49</td><td>18572072</td><td>Laboratory-based versus non-laboratory-based <b>CVD</b> risk analysis.</td></tr><tr><td>50</td><td>12975024</td><td>Reducing <b>CVD</b> risk in type 2 DM.</td></tr><tr><td>51</td><td>18060606</td><td>[Comprehensive care: <b>CVD</b> and diabetes mellitus].</td></tr><tr><td>52</td><td>20577298</td><td>Diabetes: glycated hemoglobin is a marker of diabetes and <b>CVD</b> risk.</td></tr><tr><td>53</td><td>27102038</td><td>Building a Platform to Enable NCD Research to Address Population Health in Africa: <b>CVD</b> Working Group Discussion at the Sixth H3Africa Consortium Meeting in Zambia.</td></tr><tr><td>54</td><td>18788404</td><td>[Prevention of <b>CVD</b> in patients with CKD].</td></tr><tr><td>55</td><td>17254512</td><td>Antioxidants and <b>CVD</b> in diabetes: where do we stand now.</td></tr><tr><td>56</td><td>27797933</td><td>Erratum. Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in <b>CVD</b> Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial. Diabetes Care 2016;39:1345-1355.</td></tr><tr><td>57</td><td>22632265</td><td>Diabetic <b>CVD</b>--focus on vitamin D.</td></tr><tr><td>58</td><td>29032755</td><td>Insulin Resistance the Link between T2DM and <b>CVD</b>: Basic Mechanisms and Clinical Implications.</td></tr><tr><td>59</td><td>16879779</td><td>The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and <b>CVD</b>.</td></tr><tr><td>60</td><td>15121029</td><td>Do pregnancy complications and <b>CVD</b> share common antecedents?</td></tr><tr><td>61</td><td>24078317</td><td>Preventing type 2 diabetes, <b>CVD</b>, and mortality: surgical versus non-surgical weight loss strategies.</td></tr><tr><td>62</td><td>19554008</td><td>Preventing <b>CVD</b> in resource-poor areas: perspectives from the 'real-world'.</td></tr><tr><td>63</td><td>25894803</td><td>Next generation of weight management medications: implications for diabetes and <b>CVD</b> risk.</td></tr><tr><td>64</td><td>18788391</td><td>[Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (<b>CVD</b>)].</td></tr><tr><td>65</td><td>27993594</td><td>The Effectiveness of Community Health Workers for <b>CVD</b> Prevention in LMIC.</td></tr><tr><td>66</td><td>25243024</td><td>Prediction and personalised treatment of atrial fibrillation-stroke prevention: consolidated position paper of <b>CVD</b> professionals.</td></tr><tr><td>67</td><td>15482976</td><td>Prevalence of <b>CVD</b> risk factors among adults with diabetes by mental distress status.</td></tr><tr><td>68</td><td>12880690</td><td>Pre-diabetes, insulin resistance, inflammation and <b>CVD</b> risk.</td></tr><tr><td>69</td><td>27452771</td><td>Multiple Risk Factor Interventions for Primary Prevention of <b>CVD</b> in LMIC: A Cochrane Review.</td></tr><tr><td>70</td><td>27741979</td><td>Biomarkers of Key Biological Pathways in <b>CVD</b>.</td></tr><tr><td>71</td><td>27741980</td><td>Diabetes and Clinical and Subclinical <b>CVD</b>.</td></tr><tr><td>72</td><td>22609556</td><td>Flexible glucose sensor using <b>CVD</b>-grown graphene-based field effect transistor.</td></tr><tr><td>73</td><td>28041920</td><td>Secondary <b>cvd</b> prevention-Lipid modification strategies: A critical analysis.</td></tr><tr><td>74</td><td>29050566</td><td>How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of <b>CVD</b>.</td></tr><tr><td>75</td><td>23519720</td><td>Is the risk and nature of <b>CVD</b> the same in type 1 and type 2 diabetes?</td></tr><tr><td>76</td><td>24806566</td><td>Prevalence of undiagnosed cardiovascular risk factors and 10-year <b>CVD</b> risk in male steel industry workers.</td></tr><tr><td>77</td><td>26339735</td><td>Letter to the Editor: The Article "Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality Autonomic Imbalance Predicts <b>CVD</b>, DM, Mortality" by Wulsin et al Could Resolve the "Chicken-and-Egg" Question on the Role of Sympathetic Overactivity and Insulin Resistance in Hypertension.</td></tr><tr><td>78</td><td>17349070</td><td>On the supposed influence of milk homogenization on the risk of <b>CVD</b>, diabetes and allergy.</td></tr><tr><td>79</td><td>20392507</td><td>All-cause and <b>CVD</b> mortality in Native Hawaiians.</td></tr><tr><td>80</td><td>17534087</td><td>Recognizing the link between CKD and <b>CVD</b> in the primary care setting: accurate and early diagnosis for timely and appropriate intervention.</td></tr><tr><td>81</td><td>15972289</td><td>Lipids and <b>CVD</b> management: towards a global consensus.</td></tr><tr><td>82</td><td>21128994</td><td>Plasminogen activator inhibitor-1 and HbA1c defined prediabetes: the Guangzhou Biobank Cohort Study-<b>CVD</b>.</td></tr><tr><td>83</td><td>20043505</td><td>Obstructive sleep apnoea increases risk of <b>CVD</b>.</td></tr><tr><td>84</td><td>26089876</td><td>The Chromosome 9p21 <b>CVD</b>- and T2D-Associated Regions in a Norwegian Population (The HUNT2 Survey).</td></tr><tr><td>85</td><td>16621114</td><td>Microalbuminuria presents the same vascular risk as overt <b>CVD</b> in type 2 diabetes.</td></tr><tr><td>86</td><td>23564920</td><td>Effect of type 1 diabetes on carotid structure and function in adolescents and young adults: the SEARCH <b>CVD</b> study.</td></tr><tr><td>87</td><td>21629241</td><td>Epidemiology of <b>CVD</b> in rheumatic disease, with a focus on RA and SLE.</td></tr><tr><td>88</td><td>24192590</td><td>Effect of patients' awareness of <b>CVD</b> risk factors on health-related behaviors.</td></tr><tr><td>89</td><td>26421110</td><td>Applicability of the Existing <b>CVD</b> Risk Assessment Tools to Type II Diabetics in Oman: A Review.</td></tr><tr><td>90</td><td>26148914</td><td>Nuts and <b>CVD</b>.</td></tr><tr><td>91</td><td>22382030</td><td><b>CVD</b>-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC.</td></tr><tr><td>92</td><td>27329952</td><td>Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in <b>CVD</b> Prevention Beyond Lowering LDL Cholesterol.</td></tr><tr><td>93</td><td>22632263</td><td>Diabetic <b>CVD</b>--soluble epoxide hydrolase as a target.</td></tr><tr><td>94</td><td>25267241</td><td>Oats and <b>CVD</b> risk markers: a systematic literature review.</td></tr><tr><td>95</td><td>17630950</td><td>Advanced glycation end products (AGEs) and cardiovascular disease (<b>CVD</b>) in diabetes.</td></tr><tr><td>96</td><td>18521688</td><td>Development and pilot evaluation of literacy-adapted diabetes and <b>CVD</b> education in urban, diabetic African Americans.</td></tr><tr><td>97</td><td>26411567</td><td>Approach to diabetes management in patients with <b>CVD</b>.</td></tr><tr><td>98</td><td>25736026</td><td>Insulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH <b>CVD</b> study.</td></tr><tr><td>99</td><td>15682775</td><td>A qualitative assessment of Charlotte REACH: an ecological perspective for decreasing <b>CVD</b> and diabetes among African Americans.</td></tr><tr><td>100</td><td>20003638</td><td>Session 4: <b>CVD</b>, diabetes and cancer: Evidence for the use of the Mediterranean diet in patients with CHD.</td></tr><tr><td>101</td><td>19557714</td><td>Decreased GFR estimated by MDRD or Cockcroft-Gault equation predicts incident <b>CVD</b>: the strong heart study.</td></tr><tr><td>102</td><td>28499696</td><td>Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of <b>CVD</b>?</td></tr><tr><td>103</td><td>27741477</td><td>Interleukin-18 gene polymorphism and risk of <b>CVD</b> in older patients with type 2 diabetes mellitus.</td></tr><tr><td>104</td><td>18717208</td><td>A faith-based screeningeducation program for diabetes, <b>CVD</b>, and stroke in rural African Americans.</td></tr><tr><td>105</td><td>17466109</td><td><b>CVD</b> risk in South Asians: the importance of defining adiposity and influence of dietary polyunsaturated fat.</td></tr><tr><td>106</td><td>29017904</td><td>Spicing up your advice for South Asian and Anglo-Australians with type 2 diabetes and <b>CVD</b>: Do cultural constructions of diet matter?</td></tr><tr><td>107</td><td>22961570</td><td>Reduced heart rate variability among youth with type 1 diabetes: the SEARCH <b>CVD</b> study.</td></tr><tr><td>108</td><td>18249457</td><td>Early manifestation of macrovasculopathy in newly diagnosed never treated type II diabetic patients with no traditional <b>CVD</b> risk factors.</td></tr><tr><td>109</td><td>29198154</td><td>Population trends in mitral valve surgery in Finland between 1997 and 2014: the finnish <b>CVD</b> register.</td></tr><tr><td>110</td><td>21317510</td><td>Racialethnic heterogeneity in the socioeconomic patterning of <b>CVD</b> risk factors: in the United States: the multi-ethnic study of atherosclerosis.</td></tr><tr><td>111</td><td>25211055</td><td>Diabetes and <b>CVD</b> risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients.</td></tr><tr><td>112</td><td>17343775</td><td>Mechanisms of the components of the metabolic syndrome that predispose to diabetes and atherosclerotic <b>CVD</b>.</td></tr><tr><td>113</td><td>27214974</td><td>Underestimating risk in women delays diagnosis of <b>CVD</b>.</td></tr><tr><td>114</td><td>20497213</td><td>AGEsRAGE in CKD: irreversible metabolic memory road toward <b>CVD</b>?</td></tr><tr><td>115</td><td>26425279</td><td>Association between fish and shellfish, and omega-3 PUFAs intake and <b>CVD</b> risk factors in middle-aged female patients with type 2 diabetes.</td></tr><tr><td>116</td><td>19968905</td><td>Session 4: <b>CVD</b>, diabetes and cancer: Diet, insulin resistance and diabetes: the right (pro)portions.</td></tr><tr><td>117</td><td>24267441</td><td>Progress in national and regional guidelines development and deployment for the clinical prevention and control of <b>CVD</b> and diabetes in Africa.</td></tr><tr><td>118</td><td>22487348</td><td>Markedly different clustering of <b>CVD</b> risk factors in New Zealand Indian and European people but similar risk scores (PREDICT-14).</td></tr><tr><td>119</td><td>24351674</td><td>The Counterweight programme: Prevalence of <b>CVD</b> risk factors by body mass index and the impact of 10% weight change.</td></tr><tr><td>120</td><td>26721813</td><td>Predictors of Increased Carotid Intima-Media Thickness in Youth With Type 1 Diabetes: The SEARCH <b>CVD</b> Study.</td></tr><tr><td>121</td><td>24450411</td><td>Cardiovascular health in adolescents with type 1 diabetes: the SEARCH <b>CVD</b> study.</td></tr><tr><td>122</td><td>25741874</td><td>Medicare Star excludes diabetes patients with poor <b>CVD</b> risk factor control.</td></tr><tr><td>123</td><td>28803595</td><td>Vitamin D intake and risk of <b>CVD</b> and all-cause mortality: evidence from the Caerphilly Prospective Cohort Study.</td></tr><tr><td>124</td><td>26324672</td><td>A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-<b>CVD</b>): Biomarker study.</td></tr><tr><td>125</td><td>26271552</td><td>Opportunistic Screening for <b>CVD</b> Risk Factors: The Dubai Shopping for Cardiovascular Risk Study (DISCOVERY).</td></tr><tr><td>126</td><td>24687909</td><td>Fruit and vegetable consumption and all-cause, cancer and <b>CVD</b> mortality: analysis of Health Survey for England data.</td></tr><tr><td>127</td><td>8861462</td><td>High mortality from unidentified <b>CVD</b> in IDDM: time to start screening?</td></tr><tr><td>128</td><td>25912292</td><td>Arterial stiffness in adolescents and young adults with and without type 1 diabetes: the SEARCH <b>CVD</b> study.</td></tr><tr><td>129</td><td>21314863</td><td>Predictive accuracy of the 'Framingham's general <b>CVD</b> algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.</td></tr><tr><td>130</td><td>25697289</td><td>Vitamin D and risk of <b>CVD</b>: a review of the evidence.</td></tr><tr><td>131</td><td>28892878</td><td>Role of Anthropometric Measurements in Development of <b>CVD</b> and Stroke among T2DM in East Godavari District, Andhra Pradesh, India.</td></tr><tr><td>132</td><td>21205381</td><td>Derivation of anthropometric cut-off levels to define <b>CVD</b> risk in Sri Lankan adults.</td></tr><tr><td>133</td><td>12698956</td><td>Evidence for joint action of genes on diabetes status and <b>CVD</b> risk factors in American Indians: the strong heart family study.</td></tr><tr><td>134</td><td>24010960</td><td>Impact of glycemic control on heart rate variability in youth with type 1 diabetes: the SEARCH <b>CVD</b> study.</td></tr><tr><td>135</td><td>19968904</td><td>Session 4: <b>CVD</b>, diabetes and cancer: A dietary portfolio for management and prevention of heart disease.</td></tr><tr><td>136</td><td>24101697</td><td>Cardiovascular risk factors are associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH <b>CVD</b> study.</td></tr><tr><td>137</td><td>12673782</td><td>Evidence for distinct genetic effects on obesity and lipid-related <b>CVD</b> risk factors in diabetic compared to nondiabetic American Indians: the Strong Heart Family Study.</td></tr><tr><td>138</td><td>19079434</td><td>The burden of modifiable cardiovascular risk factors in the coronary care unit by age, ethnicity, and socioeconomic status--PREDICT <b>CVD</b>-9.</td></tr><tr><td>139</td><td>26486189</td><td>Associations Between Prediabetes, by Three Different Diagnostic Criteria, and Incident <b>CVD</b> Differ in South Asians and Europeans.</td></tr><tr><td>140</td><td>24636522</td><td>High serum phosphate and triglyceride levels in smoking women and men with <b>CVD</b> risk and type 2 diabetes.</td></tr><tr><td>141</td><td>27215285</td><td>Whole-grain consumption and the risk of all-cause, <b>CVD</b> and cancer mortality: a meta-analysis of prospective cohort studies.</td></tr><tr><td>142</td><td>20054879</td><td>Brachial-ankle pulse wave velocity and cardiovascular risk factors in the non-diabetic and newly diagnosed diabetic Chinese: Guangzhou Biobank Cohort Study-<b>CVD</b>.</td></tr><tr><td>143</td><td>25213709</td><td><b>CVD</b> risk factors are related to plasma fibrin clot properties independent of total and or γ' fibrinogen concentration.</td></tr><tr><td>144</td><td>27351077</td><td>Effects of visceral adipose tissue reduction on <b>CVD</b> risk factors independent of weight loss: The Look AHEAD study.</td></tr><tr><td>145</td><td>18616850</td><td>Dietary habits mediate the relationship between socio-economic status and <b>CVD</b> factors among healthy adults: the ATTICA study.</td></tr><tr><td>146</td><td>12168353</td><td>PET-studies in idiopathic chronic hydrocephalus before and after shunt-treatment: the role of risk factors for cerebrovascular disease (<b>CVD</b>) on cerebral hemodynamics.</td></tr><tr><td>147</td><td>18653028</td><td>Prevalence of risk factors in acute ischemic cerebrovascular disease (<b>CVD</b>) in elderly patients from eastern Sicily.</td></tr><tr><td>148</td><td>17146488</td><td>Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT <b>CVD</b>-1).</td></tr><tr><td>149</td><td>20039893</td><td>The metabolic syndrome is associated with subclinical atherosclerosis independent of insulin resistance: the Guangzhou Biobank Cohort Study-<b>CVD</b>.</td></tr><tr><td>150</td><td>29259801</td><td>Treatment with liraglutide may improve markers of <b>CVD</b> reflected by reduced levels of apoB.</td></tr><tr><td>151</td><td>18377681</td><td>Flavonoid intake and the risk of ischaemic stroke and <b>CVD</b> mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study.</td></tr><tr><td>152</td><td>28865238</td><td>Association between insulin-induced weight change and <b>CVD</b> mortality: Evidence from a historic cohort study of 18,814 patients in UK primary care.</td></tr><tr><td>153</td><td>27163356</td><td>Adiposity in Children and <b>CVD</b> Risk: ApoB48 Has a Stronger Association With Central Fat Than Classic Lipid Markers.</td></tr><tr><td>154</td><td>23670978</td><td>Variants in adiponectin signaling pathway genes show little association with subclinical <b>CVD</b> in the diabetes heart study.</td></tr><tr><td>155</td><td>17391554</td><td>Whole grain intake and its cross-sectional association with obesity, insulin resistance, inflammation, diabetes and subclinical <b>CVD</b>: The MESA Study.</td></tr><tr><td>156</td><td>23239597</td><td>Elevated remnant lipoproteins may increase subclinical <b>CVD</b> risk in pre-pubertal children with obesity: a case-control study.</td></tr><tr><td>157</td><td>21323799</td><td>Prevalence and risk factors of cardiovascular disease (<b>CVD</b>) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).</td></tr><tr><td>158</td><td>26440638</td><td>Treatment with DPP-4I Anagliptin or α-GI Miglitol Reduces IGT Development and the Expression of <b>CVD</b> Risk Factors in OLETF Rats.</td></tr><tr><td>159</td><td>16459222</td><td>Effect of a low glycemic index diet with soy protein and phytosterols on <b>CVD</b> risk factors in postmenopausal women.</td></tr><tr><td>160</td><td>24250965</td><td>Incidence of Cardiovascular Risk Factors in Oskoo (Northwest Iran): An Approach through WHO <b>CVD</b>-risk Management Package for Low-and Medium-Resource Settings on 37,329 Adults ≥30 Years Old.</td></tr><tr><td>161</td><td>16616756</td><td>A comparison of the NCEP-ATPIII, IDF and AHANHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of <b>CVD</b>: evidence for sex-specific differences.</td></tr><tr><td>162</td><td>23435158</td><td>Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH <b>CVD</b> study.</td></tr><tr><td>163</td><td>25754566</td><td>The training and fieldwork experiences of community health workers conducting population-based, noninvasive screening for <b>CVD</b> in LMIC.</td></tr><tr><td>164</td><td>24168904</td><td>Associations between dairy protein intake and body weight and risk markers of diabetes and <b>CVD</b> during weight maintenance.</td></tr><tr><td>165</td><td>22318928</td><td>A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART <b>CVD</b> pilot project.</td></tr><tr><td>166</td><td>25754565</td><td>Training and supervision of community health workers conducting population-based, noninvasive screening for <b>CVD</b> in LMIC: implications for scaling up.</td></tr><tr><td>167</td><td>20934770</td><td>Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify <b>CVD</b> and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China.</td></tr><tr><td>168</td><td>22419733</td><td>Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between <b>CVD</b> risk and obesity?</td></tr><tr><td>169</td><td>26189083</td><td>Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and <b>CVD</b> in patients with CKD.</td></tr><tr><td>170</td><td>22119508</td><td>Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of <b>CVD</b>. Results from the Malmö Diet and Cancer Study.</td></tr><tr><td>171</td><td>25397456</td><td>CD4CD8 ratio is not predictive of multi-morbidity prevalence in HIV-infected patients but identify patients with higher <b>CVD</b> risk.</td></tr><tr><td>172</td><td>25669630</td><td>Ethnicity and risk of cardiovascular disease (<b>CVD</b>): 4.8 year follow-up of patients with type 2 diabetes living in Scotland.</td></tr><tr><td>173</td><td>25343719</td><td>The association between a vegetarian diet and cardiovascular disease (<b>CVD</b>) risk factors in India: the Indian Migration Study.</td></tr><tr><td>174</td><td>22841454</td><td>The contribution of stress to the social patterning of clinical and subclinical <b>CVD</b> risk factors in African Americans: the Jackson Heart Study.</td></tr><tr><td>175</td><td>24532105</td><td>Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G5G genotype frequencies of patients subjected to cardiovascular disease (<b>CVD</b>) panel in south-east region of Turkey.</td></tr><tr><td>176</td><td>25341454</td><td>Cardiovascular Disease Population Risk Tool (CVDPoRT): predictive algorithm for assessing <b>CVD</b> risk in the community setting. A study protocol.</td></tr><tr><td>177</td><td>17535429</td><td>Differences in the quality of primary medical care for <b>CVD</b> and diabetes across the NHS: evidence from the quality and outcomes framework.</td></tr><tr><td>178</td><td>27271190</td><td>Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in <b>CVD</b> Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial.</td></tr><tr><td>179</td><td>23645989</td><td>Unique and Varied Contributions of Traditional <b>CVD</b> Risk Factors: A Systematic Literature Review of CAD Risk Factors in China.</td></tr><tr><td>180</td><td>24349119</td><td>Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (<b>CVD</b>) policy model.</td></tr><tr><td>181</td><td>28575229</td><td>The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident <b>CVD</b> in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD-MIND Study.</td></tr><tr><td>182</td><td>28625949</td><td>Discussion on the risk factors of developing cardiovascular diseases (<b>CVD</b>) after the kidney transplantation.</td></tr><tr><td>183</td><td>24073676</td><td>Effectiveness of the fixed-dose combination of olmesartanamlodipinehydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic <b>CVD</b>.</td></tr><tr><td>184</td><td>27358019</td><td>The effect of dietary changes on distinct components of the metabolic syndrome in a young Sri Lankan population at high risk of <b>CVD</b>.</td></tr><tr><td>185</td><td>27264785</td><td>Association between dietary fibre intake and fruit, vegetable or whole-grain consumption and the risk of <b>CVD</b>: results from the PREvención con DIeta MEDiterránea (PREDIMED) trial.</td></tr><tr><td>186</td><td>17199721</td><td>The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and <b>CVD</b> risk in a group of overweight women with an inflammatory phenotype.</td></tr><tr><td>187</td><td>26319502</td><td>LV Mass as a Predictor of <b>CVD</b> Events in Older Adults With and Without Metabolic Syndrome and Diabetes.</td></tr><tr><td>188</td><td>24559582</td><td>Cotreatment with the α-glucosidase inhibitor miglitol and DPP-4 inhibitor sitagliptin improves glycemic control and reduces the expressions of <b>CVD</b> risk factors in type 2 diabetic Japanese patients.</td></tr><tr><td>189</td><td>28771923</td><td>Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (<b>CVD</b>-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study.</td></tr><tr><td>190</td><td>19828159</td><td>Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-<b>CVD</b>.</td></tr><tr><td>191</td><td>28255249</td><td>Association between obesity and heart rate variability indices: an intuition toward cardiac autonomic alteration - a risk of <b>CVD</b>.</td></tr><tr><td>192</td><td>23805252</td><td>Excess Cardiovascular Risk Burden in Jamaican Women Does Not Influence Predicted 10-Year <b>CVD</b> Risk Profiles of Jamaica Adults: An Analysis of the 200708 Jamaica Health and Lifestyle Survey.</td></tr><tr><td>193</td><td>27438317</td><td>Effect of Targeting Inflammation With Salsalate: The TINSAL-<b>CVD</b> Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins.</td></tr><tr><td>194</td><td>20819236</td><td>Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART <b>CVD</b>) pilot study.</td></tr><tr><td>195</td><td>22257700</td><td>Co-morbid depression is associated with poor work outcomes in persons with cardiovascular disease (<b>CVD</b>): a large, nationally representative survey in the Australian population.</td></tr><tr><td>196</td><td>17339901</td><td>Assessing Māorinon-Māori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT <b>CVD</b>-2).</td></tr><tr><td>197</td><td>22250063</td><td>Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year <b>CVD</b> risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial.</td></tr><tr><td>198</td><td>27840384</td><td>Association of Subjective and Objective Sleep Duration as well as Sleep Quality with Non-Invasive Markers of Sub-Clinical Cardiovascular Disease (<b>CVD</b>): A Systematic Review.</td></tr><tr><td>199</td><td>21981988</td><td>Prevalence of peripheral arterial disease in subjects with moderate cardiovascular risk: Italian results from the PANDORA study Data from PANDORA (Prevalence of peripheral Arterial disease in subjects with moderate <b>CVD</b> risk, with No overt vascular Diseases nor Diabetes mellitus).</td></tr><tr><td>200</td><td>26652917</td><td>Cardiovascular risk factors awareness and prevalence among primary care physicians: an insight from the West region Awareness Initiative Survey to fight cardiovascular disease (WAIT-<b>CVD</b>) in Cameroon.</td></tr><tr><td>201</td><td>20186243</td><td>A comparative analysis of the cardiovascular disease risk factor profiles of Pacific peoples and Europeans living in New Zealand assessed in routine primary care: PREDICT <b>CVD</b>-11.</td></tr><tr><td>202</td><td>25925238</td><td>Prevalence of cardiovascular disease risk factors among a Nigerian adult population: relationship with income level and accessibility to <b>CVD</b> risks screening.</td></tr><tr><td>203</td><td>22947342</td><td>Reducing salt intake for prevention of cardiovascular diseases in high-risk patients by advanced health education intervention (RESIP-<b>CVD</b> study), Northern Thailand: study protocol for a cluster randomized trial.</td></tr><tr><td>204</td><td>12542011</td><td>Established cardiovascular disease and <b>CVD</b> risk factors in a primary care population of middle-aged Irish men and women.</td></tr><tr><td>205</td><td>25862452</td><td>Cardiovascular disease (<b>CVD</b>) risk factors in Kraków and in the whole Poland adult population. Results from the WOBASZ study and Polish arm of the HAPIEE project.</td></tr><tr><td>206</td><td>28522450</td><td>Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The <b>CVD</b>-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).</td></tr><tr><td>207</td><td>21317960</td><td>A comparative analysis of cardiovascular disease risk profiles of five Pacific ethnic groups assessed in New Zealand primary care practice: PREDICT <b>CVD</b>-13.</td></tr><tr><td>208</td><td>28781064</td><td>Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (<b>CVD</b>-REAL Nordic): a multinational observational analysis.</td></tr>
	</tbody></table>

	</body></html>
	